BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2532272)

  • 1. Epitestosterone--an endogenous antiandrogen?
    Stárka L; Bicíková M; Hampl R
    J Steroid Biochem; 1989 Nov; 33(5):1019-21. PubMed ID: 2532272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Does epitestosterone function as an endogenous antiandrogen?].
    Bicíková M; Hampl R; Stárka L
    Cas Lek Cesk; 1989 Jun; 128(24):754-5. PubMed ID: 2527599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiandrogenic activity of epitestosterone in male mice in vivo.
    Stárka L; Broulík PD
    Sb Lek; 2001; 102(1):7-11. PubMed ID: 11830921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of antiandrogen cyproterone acetate on the action of testosterone on mouse kidney.
    Broulik P; Stárka L; Ston J
    Physiol Bohemoslov; 1975; 24(3):221-7. PubMed ID: 124891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions of an anti-androgen (cyproterone acetate) with the androgen receptor system and its biological action in the rat ventral prostate.
    Huang JK; Bartsch W; Voigt KD
    Acta Endocrinol (Copenh); 1985 Aug; 109(4):569-76. PubMed ID: 2930988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen receptor binding and antiandrogenic activity of some 4,5-secoandrostanes and ring B cyclopropanoandrostanes.
    Stárka L; Hampl R; Kasal A; Kohout L
    J Steroid Biochem; 1982 Sep; 17(3):331-4. PubMed ID: 6215537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyproterone acetate prevents translocation of the androgen receptor in the rat prostate.
    Brinkmann AO; Lindh LM; Breedveld DI; Mulder E; Van Der Molen HJ
    Mol Cell Endocrinol; 1983 Oct; 32(2-3):117-29. PubMed ID: 6227511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a new topically active antiandrogen (RU 38882) on the rat sebaceous gland: comparison with cyproterone acetate.
    Bouton MM; Lecaque D; Secchi J; Tournemine C
    J Invest Dermatol; 1986 Feb; 86(2):163-7. PubMed ID: 2943819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiandrogenic properties of nomegestrol acetate.
    Duc I; Botella J; Bonnet P; Fraboul F; Delansorne R; Paris J
    Arzneimittelforschung; 1995 Jan; 45(1):70-4. PubMed ID: 7893274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of non-classical effects of testosterone and epitestosterone on AMH balance and testicular development parameters.
    da Rosa LA; Escott GM; Simonetti RB; da Silva JCD; Werlang ICR; Goldani MZ; de Fraga LS; Loss EDS
    Mol Cell Endocrinol; 2020 Jul; 511():110850. PubMed ID: 32387527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen receptor in rat skeletal muscle: characterization and physiological variations.
    Michel G; Baulieu EE
    Endocrinology; 1980 Dec; 107(6):2088-98. PubMed ID: 6968675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imprinting of male sex tissues by neonatal endogenous androgens in mice. Molecular alterations following exposure to cyproterone acetate.
    Jean-Faucher C; Berger M; Gallon C; de Turckheim M; Veyssière G; Jean C
    Horm Res; 1986; 24(1):38-45. PubMed ID: 2944809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of antiandrogens casodex and epitestosterone on bone composition in mice.
    Broulik PD; Stárka L
    Bone; 1997 May; 20(5):473-5. PubMed ID: 9145245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epitestosterone--a potent competitive inhibitor of C21-steroid side chain cleavage in the testis.
    Bicíková M; Hampl R; Stárka L
    J Steroid Biochem Mol Biol; 1992 Dec; 43(7):721-4. PubMed ID: 1472464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epitestosterone- and testosterone-replacement in immature castrated rats changes main testicular developmental characteristics.
    Cavalari FC; da Rosa LA; Escott GM; Dourado T; de Castro AL; Kohek MBDF; Ribeiro MFM; Partata WA; de Fraga LS; Loss EDS
    Mol Cell Endocrinol; 2018 Feb; 461():112-121. PubMed ID: 28870779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged influence of a neonatal cyproterone acetate treatment on renal androgen binding in mice.
    Veyssière G; Gallon C; Berger M; Jean-Faucher C; de Turckheim M; Jean C
    Acta Endocrinol (Copenh); 1988 Oct; 119(2):263-8. PubMed ID: 2972151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoids and aspirin inhibit and cyproterone acetate enhances the androgenic response in mouse kidney.
    Goldstone AD; Koenig H; Blume G; Lu CY
    Biochim Biophys Acta; 1981 Sep; 677(1):133-9. PubMed ID: 6271247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of in vivo administration of 5 alpha reductase inhibitors on epididymal function.
    de Larminat MA; Blaquier JA
    Acta Physiol Lat Am; 1979; 29(1):1-6. PubMed ID: 263219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The biological activity of 7 alpha-methyl-19-nortestosterone is not amplified in male reproductive tract as is that of testosterone.
    Kumar N; Didolkar AK; Monder C; Bardin CW; Sundaram K
    Endocrinology; 1992 Jun; 130(6):3677-83. PubMed ID: 1597164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cyproterone acetate on growth and androgen metabolism of rat ventral prostate transplants.
    Thomas JA; Edwards WD; Felice PR
    Endocrinol Exp; 1981 Sep; 15(3):171-9. PubMed ID: 6457737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.